105 related articles for article (PubMed ID: 6090175)
21. In vivo effects of a novel thromboxane A2/prostaglandin H2 (TXA2/PGH2) partial agonist, (+)5(Z)-7-[3-endo-phenylsulfonylamino[2.2.1]- bicyclohept-2-exo-yl]-heptenoic acid [(+)-S-145], on vascular, platelet and cardiac function.
Dubé GP; Jakubowski JA; Brune KA; Bemis KG; Kurtz WL
J Pharmacol Exp Ther; 1995 Feb; 272(2):799-807. PubMed ID: 7853197
[TBL] [Abstract][Full Text] [Related]
22. Involvement of prostanoids in the pulmonary pressor effect of histamine.
Akar F; Kanzik I
Prostaglandins Leukot Essent Fatty Acids; 1989 Jul; 37(1):25-9. PubMed ID: 2527372
[TBL] [Abstract][Full Text] [Related]
23. Arachidonic acid and pulmonary function in heart-lung-preparation of guinea-pig: modulation by PCO2.
Bedetti C; Del Basso P; Argiolas L; Carpi A
Arch Int Pharmacodyn Ther; 1987 Jan; 285(1):98-116. PubMed ID: 3107484
[TBL] [Abstract][Full Text] [Related]
24. Analysis of bronchoconstrictor responses to platelet-activating factor in the cat.
Underwood DC; Kadowitz PJ
J Appl Physiol (1985); 1989 Jul; 67(1):377-82. PubMed ID: 2759966
[TBL] [Abstract][Full Text] [Related]
25. Differential antagonism of airway contractile responses to prostaglandin (PG)D2 and 9 alpha, 11 beta-PGF2 by atropine, SK&F 88046 and SQ 29,548 in the guinea pig.
Underwood DC; Muccitelli RM; Luttmann MA; Hay DW; Torphy TJ; Wasserman MA
J Pharmacol Exp Ther; 1994 Jan; 268(1):304-10. PubMed ID: 8301572
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
[TBL] [Abstract][Full Text] [Related]
27. Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.
Dorn GW; Burch RM; Kochel PJ; Mais DE; Halushka PV
Biochem Pharmacol; 1987 Jun; 36(12):1913-7. PubMed ID: 2954555
[TBL] [Abstract][Full Text] [Related]
28. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
[TBL] [Abstract][Full Text] [Related]
29. Binding of a radioiodinated agonist to thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors in guinea pig lung membranes.
Mais DE; Saussy DL; Magee DE; Williams CM
Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():347-50. PubMed ID: 1825567
[No Abstract] [Full Text] [Related]
30. Pharmacological actions of SQ 29,548, a novel selective thromboxane antagonist.
Ogletree ML; Harris DN; Greenberg R; Haslanger MF; Nakane M
J Pharmacol Exp Ther; 1985 Aug; 234(2):435-41. PubMed ID: 3926986
[TBL] [Abstract][Full Text] [Related]
31. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
32. Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo.
Darius H; Smith JB; Lefer AM
J Pharmacol Exp Ther; 1985 Nov; 235(2):274-81. PubMed ID: 2997428
[TBL] [Abstract][Full Text] [Related]
33. Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.
Ciabattoni G; Montuschi P; Currò D; Togna G; Preziosi P
Br J Pharmacol; 1993 May; 109(1):243-50. PubMed ID: 8495242
[TBL] [Abstract][Full Text] [Related]
34. Effect of a thromboxane receptor antagonist on PGD2- and allergen-induced bronchoconstriction.
Beasley RC; Featherstone RL; Church MK; Rafferty P; Varley JG; Harris A; Robinson C; Holgate ST
J Appl Physiol (1985); 1989 Apr; 66(4):1685-93. PubMed ID: 2525122
[TBL] [Abstract][Full Text] [Related]
35. A thromboxane mimetic, U-46619, produces plasma exudation in airways of the guinea pig.
Lötvall J; Elwood W; Tokuyama K; Sakamoto T; Barnes PJ; Chung KF
J Appl Physiol (1985); 1992 Jun; 72(6):2415-9. PubMed ID: 1385805
[TBL] [Abstract][Full Text] [Related]
36. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed.
McMahon TJ; Hood JS; Nossaman BD; Ibrahim IN; Feng CJ; Kadowitz PJ
J Appl Physiol (1985); 1991 Nov; 71(5):2012-8. PubMed ID: 1837015
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
Valentin JP; Bessac AM; Maffre M; John GW
Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
[TBL] [Abstract][Full Text] [Related]
38. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.
Rump LC; Schollmeyer P
Br J Pharmacol; 1989 Jul; 97(3):819-28. PubMed ID: 2503228
[TBL] [Abstract][Full Text] [Related]
39. Role of arachidonate metabolites in C5a-induced bronchoconstriction.
Regal JF
J Pharmacol Exp Ther; 1988 Aug; 246(2):542-7. PubMed ID: 2841450
[TBL] [Abstract][Full Text] [Related]
40. Effect of the thromboxane receptor antagonist EP 092 on endotoxin shock in the sheep.
Armstrong RA; Jones RL; Wilson NH
Prostaglandins; 1985 May; 29(5):703-13. PubMed ID: 2989977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
